National Cancer Institute National Cancer Institute
U.S. National Institutes of Health National Cancer Institute
Dictionary of Cancer Terms
Send to Printer
BB-10901

 A substance that combines a monoclonal antibody (huN901) with an anticancer drug (DM1), and is being studied in the treatment of certain cancers, including non-small cell lung cancer. Monoclonal antibodies are laboratory-produced substances that can locate and bind to cancer cells.

Previous Definitions:batracylin, BAY 12-9566, BAY 43-9006, BAY 56-3722, BAY 59-8862
Next Definitions:BBBD, BBIC, BBR 2778, BBR 3464, BCG